The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Neeraj Agarwal
Research Funding - Amgen (Inst); Arvinas (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celldex (Inst); crispr therapeutics (Inst); Eisai (Inst); Exelixis (Inst); Genentech (Inst); Gilead Sciences (Inst); Immunomedics (Inst); Janssen (Inst); Lilly (Inst); Merck (Inst); Nektar (Inst); ORIC Pharmaceuticals (Inst); ORIC Pharmaceuticals (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Exelixis; Pfizer
 
Pedro Barata
Stock and Other Ownership Interests - Luminate Medical
Honoraria - Medscape; UroToday
Consulting or Advisory Role - Astellas Medivation; AstraZeneca; AVEO; Bayer; BMS; Caris Life Sciences; Dendreon (Inst); Eisai; EMD Serono; Exelixis; Ipson; Merck; Novartis; Pfizer
Speakers' Bureau - Astellas Pharma; AstraZeneca
Research Funding - AVEO (Inst); Blue Earth Diagnostics (Inst); Exelixis; Merck (Inst); Pfizer (Inst)
 
Cynthia Healy
Employment - Pfizer; PRA Health Sciences (I)
Stock and Other Ownership Interests - Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Xun Lin
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Fernando Maluf
Honoraria - Astellas Pharma; AstraZeneca; Bayer Schering Pharma; BMS Brazil; Ipsen; Janssen Oncology; Merck Serono; Merck Sharp & Dohme; Roche/Genentech; Sanofi/Aventis
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer Schering Pharma; BMS Brazil; ipsen; Janssen Oncology; Merck Serono; Merck Sharp & Dohme; Roche/Genentech
Research Funding - Janssen-Cilag (Inst); Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - Bayer Schering Pharma; Merck Sharp & Dohme
 
Axel Merseburger
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Eisai; Ipsen; Janssen-Cilag; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Clovis Oncology; Ipsen; Janssen-Cilag; MSD Oncology; Takeda
Speakers' Bureau - Ipsen; Johnson & Johnson/Janssen
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Janssen-Cilag (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Ipsen; Janssen-Cilag
 
Kevin Sokolowski
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Dingwei Ye
No Relationships to Disclose
 
Stephen Freedland
Employment - Genomic Health (I)
Stock and Other Ownership Interests - Caper Labs; Hessian Labs
Honoraria - Astellas Pharma; Pfizer
Consulting or Advisory Role - A3P Biomedical; Astellas Pharma; AstraZeneca; Bayer; Caper Labs; Clovis Oncology; Dendreon; Exact Sciences; Exosome Diagnostics; Ferring; Hessian Labs; Janssen Biotech; Lilly; LynxDx; Merck; Myovant Sciences; Novartis; Pfizer; Sanofi; Tempus; Tolmar
Speakers' Bureau - AstraZeneca; Sanofi
Research Funding - Bayer (Inst); Diasorin; GenomeDx (Inst); Janssen Biotech (Inst); MDxHealth (Inst); Merck; Myriad Genetics (Inst); OPKO Diagnostics (Inst); Progenika (Inst)
Travel, Accommodations, Expenses - Sanofi